“Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Phase III Clinical Trials Pooled Analysis Results”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s102, https://doi.org/10.25251/skin.1.supp.101.